Stock Market & Financial Investment News

News Breaks January 24, 2013 07:14 EDT ARIA ARIAD shares should be bought following pullback, says RBC Capital RBC Capital recommends buying ARIAD's stock at current levels, as the firm believes that the launch of the company's Iclusig drug will meet or beat consensus during its initial stages. The firm believes that upcoming data for the company's '113 drug will provide a positive catalyst to the stock and it maintains an Outperform rating. News For ARIA From The Last 14 Days Check below for free stories on ARIA the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 20, 2013 07:34 EDT ARIA UBS to host a conference Subscribe for More Information May 17, 2013 08:22 EDT ARIA ARIAD shares should be bought on weakness, says BMO Capital Subscribe for More Information May 16, 2013 07:29 EDT ARIA Leerink to host a bus tour Boston Biopharma Bus Tour travels throughout Boston on May 16-17. Sign up for a free trial to see the rest of the stories you've been missing.